Preliminary Results of a Phase II Trial of Dose-Intense PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) in Advanced Pancreatic Adenocarcinoma

(Journal Article): Preliminary Results of a Phase II Trial of Dose-Intense PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) in Advanced Pancreatic Adenocarcinoma

Cereda S, Dell'Oro S, Passoni P, Bonetto E, Viganò MG, Balzano G, Zerbi A, Staudacher C, Di Carlo V, Reni M (Department of Oncology and Surgery, S. Raffaele H. Scientific Institute. Milan, Italy)

IN: JOP. J Pancreas (Online) 2005; 06(5 Suppl.):481-482

Fulltext: HTML PDF

TYPE OF PUBLICATION: Conference Abstract

Respond on this Journal Article!
Hint: Your Response should directly apply to Preliminary Results of a Phase II Trial of Dose-Intense PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) in Advanced Pancreatic Adenocarcinoma. Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate subject area. The actual subject area is 2005.